Skip to Main Content

Author Details

Alexander U Brandt
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
2007
212
46
PMIDPaper TitleJournal TitlePublished Year
37903651Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis.Ann Clin Transl Neurol2024
37721679Digital Motor Biomarkers of Cerebellar Ataxia Using an RGB-Depth Camera-Based Motion Analysis System.Cerebellum2024
36635219Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.Eur J Neurol2023
37782525Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSD.J Neuroophthalmol2023
37641618Functional connectome fingerprinting and stability in multiple sclerosis.Mult Scler J Exp Transl Clin2023
37413855Discrimination of multiple sclerosis using OCT images from two different centers.Mult Scler Relat Disord2023
37433662Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.J Neurol Neurosurg Psychiatry2023
36625888Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.J Neurol2023
36878713Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal Cohort.Neurol Neuroimmunol Neuroinflamm2023
36810323Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.J Neurol Neurosurg Psychiatry2023
36706773Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.Lancet Neurol2023
34711650Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.J Neurol Neurosurg Psychiatry2022
35772194Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study.Neuroimage Clin2022
35441135Central stress processing, T-cell responsivity to stress hormones and disease severity in multiple sclerosis.Brain Commun2022
35703428Longitudinal Retinal Changes in MOGAD.Ann Neurol2022
35764402The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.Neurology2022
35427382Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: A preliminary study.PLoS One2022
35363150Proposal for Post Hoc Quality Control in Instrumented Motion Analysis Using Markerless Motion Capture: Development and Usability Study.JMIR Hum Factors2022
35621903Intraretinal Layer Segmentation Using Cascaded Compressed U-Nets.J Imaging2022
36517734Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study.BMC Neurol2022
35904793Central Macular Topographic and Volumetric Measures: New Biomarkers for Detection of Glaucoma.Transl Vis Sci Technol2022
36266394Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.Sci Rep2022
36285339Prior optic neuritis detection on peripapillary ring scans using deep learning.Ann Clin Transl Neurol2022
36049341Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.Mult Scler Relat Disord2022
36049213Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort.J Neuroophthalmol2022
34379018Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders.Mult Scler2022
34548173Modular deep neural networks for automatic quality control of retinal optical coherence tomography scans.Comput Biol Med2022
33063293Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1.Cerebellum2021
33910937APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies.Neurology2021
33796330A novel investigation method for axonal damage in neuromyelitis optica spectrum disorder: In vivo corneal confocal microscopy.Mult Scler J Exp Transl Clin2021
33547839Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive.Eur J Neurol2021
33739604Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult-onset disorder.Ann Clin Transl Neurol2021
33622766Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial.Neurol Neuroimmunol Neuroinflamm2021
33762428Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial.Neurol Neuroimmunol Neuroinflamm2021
33735786Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study.Neuroimage Clin2021
33782636Cultural bias in motor function patterns: Potential relevance for predictive, preventive, and personalized medicine.EPMA J2021
33856249Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation.Mult Scler2021
34887828Neural Processes of Psychological Stress and Relaxation Predict the Future Evolution of Quality of Life in Multiple Sclerosis.Front Neurol2021
34759023Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine.Neurol Neuroimmunol Neuroinflamm2021
33995239Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study.Front Neurol2021
33970182Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration.JAMA Neurol2021
34017610AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.Mult Scler J Exp Transl Clin2021
34348969Increased Serum Neurofilament Light and Thin Ganglion Cell-Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis.Neurol Neuroimmunol Neuroinflamm2021
33933106Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.J Neuroinflammation2021
34284398Cognitive Impairment in Multiple System Atrophy Is Related to White Matter Damage Detected by the T1-Weighted/T2-Weighted Ratio.Eur Neurol2021
33185857Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosis.Acta Neurol Belg2021
33241514Magnetic resonance T1w/T2w ratio in the middle cerebellar peduncle might be a sensitive biomarker for multiple system atrophy.Eur Radiol2021
31264181Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders.Acta Neurol Belg2020
32047645High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial.Mult Scler J Exp Transl Clin2020
31796527Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.Neurology2020
  • 1 - 50 of 212

Recommended Authors

Center for Translational Neuro- and Behavioral Sciences, University Medicine Essen
Career Start Year 2017
Number of shared co-authors 0
University of London
Career Start Year 2015
Number of shared co-authors 4
University of Washington
Career Start Year 2014
Number of shared co-authors 1
Institute of Ophthalmology, University College London
Career Start Year 2013
Number of shared co-authors 2
University of Arizona College of Medicine
Career Start Year 2013
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 2010
Number of shared co-authors 0
University of Manchester
Career Start Year 2009
Number of shared co-authors 2
Google Health
Career Start Year 2009
Number of shared co-authors 1
University of British Columbia
Career Start Year 2008
Number of shared co-authors 0
Hospital de Clinicas de Porto Alegre
Career Start Year 2007
Number of shared co-authors 4
Shiley Eye Institute, University of California
Career Start Year 2007
Number of shared co-authors 0
St. Vincent's University Hospital
Career Start Year 2007
Number of shared co-authors 1
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2006
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 10
The University of Texas Southwestern Medical Center
Career Start Year 2003
Number of shared co-authors 10
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2003
Number of shared co-authors 5
Duke University Medical Center
Career Start Year 2002
Number of shared co-authors 1
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 2
University Hospitals Birmingham NHS Foundation Trust
Career Start Year 2000
Number of shared co-authors 4
Institute of Molecular and Clinical Ophthalmology Basel
Career Start Year 1999
Number of shared co-authors 3
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1999
Number of shared co-authors 4
Singapore Eye Research Institute
Career Start Year 1997
Number of shared co-authors 1
Heersink School of Medicine, University of Alabama-Birmingham
Career Start Year 1997
Number of shared co-authors 1
Royal Perth Hospital
Career Start Year 1997
Number of shared co-authors 1
Children's Hospital of Philadelphia
Career Start Year 1996
Number of shared co-authors 7
The University of Hong Kong
Career Start Year 1996
Number of shared co-authors 3
National Eye Institute
Career Start Year 1995
Number of shared co-authors 0
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 4
University of Pennsylvania/Ophthalmology
Career Start Year 1993
Number of shared co-authors 7
Bascom Palmer Eye Institute
Career Start Year 1986
Number of shared co-authors 2

Collaborators

Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 182
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 91
Charite School of Medicine and University Hospital Berlin
Co-authored papers 42
Moorfields Eye Hospital
Co-authored papers 17
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig Maximilians University
Co-authored papers 16
Fundacio Recerca Clinic Barcelona -IDIBAPS
Co-authored papers 15
Johns Hopkins University School of Medicine
Co-authored papers 14
Co-authored papers 13
Johns Hopkins University School of Medicine
Co-authored papers 12
Hospital Clinic of Barcelona-Institut d'Investigacions
Co-authored papers 12
University Hospital Basel
Co-authored papers 12
Vrije Universiteit Amsterdam
Co-authored papers 12
Technical University of Munich
Co-authored papers 11
Co-authored papers 11
Vita-Salute University & Hospital San Raffaele
Co-authored papers 10
TUM School of Medicine, Technical University of Munich
Co-authored papers 9
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 9
Oxford University
Co-authored papers 8
Stanford University School of Medicine
Co-authored papers 5
Technical University of Munich
Co-authored papers 5
Stanford University School of Medicine
Co-authored papers 5
NYU Grossman School of Medicine
Co-authored papers 4
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 4
Ibn Sina Hospital
Co-authored papers 4
NYU Grossman School of Medicine
Co-authored papers 3
Co-authored papers 3
McGill University
Co-authored papers 3
Dasman Institute
Co-authored papers 3
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Co-authored papers 3
Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem
Co-authored papers 3